Is a good buy rmti now ?

**Rockwell Medical, Inc. (RMTI) does not appear to be a good buy at this time**, based on the following analysis: 1. **Financial Metrics**: RMTI's Price to Book Ratio is 3.12, Price to Sales Ratio is 0.75, and Price to Earnings (TTM) Ratio is -15.35. These ratios suggest that the stock is relatively expensive compared to the company's book value and sales, and it is currently unprofitable as indicated by the negative P/E ratio. |Ticker|Name|Date|P/E(TTM)|P/S|Price to Book Ratio|code|market_code| |---|---|---|---|---|---|---|---| |RMTI.O|Rockwell Medical|20240814|-15.346042|0.7548374956708173|3.1164913813941606|RMTI|186| 2. **Technical Indicators**: The stock's 5-day moving average is $2.29, which is higher than the 10-day moving average of $2.03 and the 50-day moving average of $1.9. This indicates a short-term upward trend but also suggests that the stock may be overbought in the near term. 3. **Market Sentiment**: There is a strong buy consensus rating with an average price target of $9, which represents a significant upside from the current price. However, given the stock's current financial metrics and technical indicators, the high price target may be overly optimistic. 4. **Fund Flow**: The net fund flow is positive at $27,609.58, which could indicate investor interest or speculative activity, but it does not necessarily reflect the stock's intrinsic value. In conclusion, while there is a strong buy consensus and positive fund flow, the stock's financial metrics and technical indicators suggest caution. Potential investors should consider the high price target in the context of the company's financial health and market conditions before making a decision.